|
TOP STORIES
Drug Attacks Cancer Stem Cells
A compound that appears to target the master cells which help breast cancers grow and spread has been discovered by US scientists. [Whitehead Institute for Biomedical Research, MIT, Massachusetts]
SPECIAL FEATURE
Mammary Stem Cells: Learn Cutting-Edge, Robust Functional Assays to Evaluate MaSCs
STEMCELL Technologies is offering a 2-day Mammary Stem Cell Training Course that provides hands-on instruction in the dissection, culture, identification and enumeration of mammary stem and progenitor cells.
October 17-18, 2009, Vancouver, Canada
View Curriculum / Register
|
|
SCIENCE NEWS
Scientists Find Common Trigger in Cancer and Normal Stem Cell Production
Researchers have discovered a common molecular pathway that is used by both normal stem cells and cancer stem cells when they reproduce themselves.
Video [School of Medicine, Stanford University, Palo Alto]
LSUHSC Research Discovers New Targets for Treatment of Invasive Breast Cancer
miR-27b, a novel microRNA, not only inactivates the ST14 gene which they found suppresses the growth of breast tumor cells, but also that miR-27b stimulates the breast cancer to invade other cells. [LSU Health Sciences Center, New Orleans]
Estrogen-Dependent Switch Tempers Killing Activity of Immune Cells
Modulated by estrogen, EBAG9 tempers the activity of Cytotoxic T-cells (CTL). In the absence of EBAG9, the activity of CTLs is enhanced.
[Max Delbrück Center for Molecular Medicine, Berlin]
Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival (PFS) in Women with Previously Treated Advanced Breast Cancer
Genentech, Inc. today announced that a Phase III study (RIBBON 2) of Avastin® (bevacizumab) in combination with chemotherapy increased the time women with metastatic HER2-negative breast cancer whose initial chemotherapy had stopped working lived without the disease worsening (progression-free survival or PFS), compared to chemotherapy alone. [Genentech Inc., San Francisco]
Study Supports DNA Repair-Blocker Research in Cancer Therapy
Scientists have uncovered the mechanism behind a promising new approach to cancer treatment: damaging cancer cells' DNA with potent drugs while simultaneously preventing the cells from repairing themselves. [Dana-Farber Cancer Institute, Boston]
|
|
|
Events
Next Generation Comprehensive Breast Centers of Excellence
September 29-October 2, 2009
Baltimore, MD, United States
2009 National Cancer Research Institute Conference
October 4-7, 2009
Birmingham, United Kingdom
Global Breast Cancer Conference
October 8-10, 2009
Seoul, South Korea
Gordon Research Conference - Stem Cells and Cancer
September 13-18, 2009
Les Diablerets, Switzerland
AACR - Advances in Breast Cancer Research
October 13-16, 2009
San Diego, CA, United States
32nd Annual CTRC - AACR San Antonio Breast Cancer Symposium
December 9-13, 2009
San Antonio, TX
Gordon Research Conference - Mammary Gland Biology
June 6-11, 2010
Lucca (Barga), Italy
The 21st Meeting of the European Association for Cancer Research
June 26-29, 2010
Oslo, Norway
Visit our events page
to stay up to date with the latest events in the cell, gene and immunotherapy community.
Have we missed an important article or publication in Mammary Cell News? Click here to submit!
|
|
|
This email was sent by: Connexon Creative
400-570 W. 7th Avenue Vancouver, British Columbia V5Z 1B3 Canada |
|
|
